TY  - ADVS
AU  - Harris,Claire L.
TI  - Complement as a therapeutic target
T2  - Macular degeneration,
PY  - 2017///
CY  - London
PB  - Henry Stewart Talks
KW  - Complement (Immunology)
KW  - Drug development
KW  - Retinal degeneration
KW  - Treatment
KW  - Clinical Trials, Phase III as Topic
KW  - Complement Activation
KW  - drug effects
KW  - immunology
KW  - Complement Inactivating Agents
KW  - pharmacology
KW  - Complement Inactivator Proteins
KW  - Complement System Proteins
KW  - Drug Design
KW  - Drug Discovery
KW  - eculizumab
KW  - Macular Degeneration
KW  - drug therapy
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Physiological roles of complement -- Complement activation and control -- Complement-mediated disease -- The challenges of complement drug discovery -- Current drugs in the clinic, highlights and drawbacks -- Strategies for complement inhibition -- The current anti-complement drug development landscape; Access restricted to subscribers
UR  - https://hstalks.com/bs/3620/
UR  - https://hstalks.com/bs/p/1036/
UR  - https://hstalks.com/bs/p/979/
ER  -